PPA
EVLO

Parametric Portfolio Associates’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History

Parametric Portfolio Associates’s Portfolio EVLO Stock Details EVLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$123K Buy
1,811
+807
+80% +$67.2K ﹤0.01% 3530
2021
Q4 		$122K Hold
1,004
– – ﹤0.01% 3527
2021
Q3 		$141K Sell
1,004
-107
-10% -$21.2K ﹤0.01% 3492
2021
Q2 		$305K Sell
1,111
-300
-21% -$75.7K ﹤0.01% 3268
2021
Q1 		$302K Buy
1,411
+787
+126% +$218K ﹤0.01% 3714
2020
Q4 		$151K Buy
+624
New +$77.2K ﹤0.01% 3840

Other funds holding EVLO

FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $170M AUM 34.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $22.6B AUM 40.24% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Parametric Portfolio Associates's EVLO Position: Q1 2022 in Review

Parametric Portfolio Associates increased its Evelo Biosciences, Inc. Common Stock (EVLO) stake by 80% in Q1 2022, buying an estimated $67.2K and bringing the position to 1,811 shares worth $123K. The position accounts for ﹤0.01% of the portfolio, ranked #3530.

Parametric Portfolio Associates first reported a position in EVLO in Q4 2020 and has held it in 6 quarters since. The position peaked at $305K in Q2 2021. 68 funds tracked by Wall St. Rank hold EVLO as of Q1 2022.

  • Parametric Portfolio Associates held 1,811 shares of Evelo Biosciences, Inc. Common Stock worth $123K as of Q1 2022.
  • Parametric Portfolio Associates bought 807 Evelo Biosciences, Inc. Common Stock shares in Q1 2022, an estimated $67.2K.
  • Evelo Biosciences, Inc. Common Stock made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #3530 holding.
  • Parametric Portfolio Associates first reported a position in Evelo Biosciences, Inc. Common Stock in Q4 2020 and has held it in 6 quarters since.
  • Parametric Portfolio Associates's Evelo Biosciences, Inc. Common Stock position peaked at $305K in Q2 2021.
  • 68 funds tracked by Wall St. Rank held Evelo Biosciences, Inc. Common Stock as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.